Could a lower dose of regorafenib help fight a rare cancer?
NCT ID NCT02098538
First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 26 times
Summary
This study tested the drug regorafenib in 38 people with a rare cancer called adenoid cystic carcinoma that had spread or come back. Regorafenib is already approved for other cancers, but this trial used a lower starting dose to reduce side effects. The goal was to see if the drug could shrink tumors or stop them from growing, and to monitor safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOID CYSTIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
Basking Ridge, New Jersey, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Cancer Center @ Suffolk
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Westchester
Harrison, New York, 10604, United States
-
Memorial Sloan Kettering at Mercy Medical Center
Rockville Centre, New York, United States
Conditions
Explore the condition pages connected to this study.